Albert Friesen

Albert Friesen

Chief Executive Officer chez MEDICURE INC.

Fortune : 3 M $ au 31/03/2024

77 ans
Health Technology
Finance
Commercial Services

Profil

Albert D.
Friesen
is the founder of Viventia Biotech, Inc. (founded in 1995), Medicure, Inc. (founded in 1997), Luminor Medical Technologies, Inc. (founded in 1998), and Genesys Venture, Inc. (founded in 1997).
He holds the title of Chairman & Chief Executive Officer at Medicure, Inc., Chairman at Luminor Medical Technologies, Inc., and President at Genesys Venture, Inc. Dr. Friesen was also the founder of Winnipeg RH Institute Foundation, Inc., ABI Biotechnology, Inc., Genesys Pharma, Inc., KAM Scientific, Inc., and Industrial Biotechnology Association of Canada.
His current job(s) include Chief Executive Officer at CentreStone Ventures, Inc. (since 2006), Chairman, President & Chief Executive Officer at Marsala Biotech Inc, Co-Chairman at Manitoba Innovation Council, Chairman at Waverley Pharma, Inc. (since 2016), Director at Mylan API, Inc., Director at Magellan Biotech, Inc., Director at Canada Foundation for Innovation (since 2010), and Director at Sensible Medical Innovations Ltd.
(since 2019).
His former job(s) include Chief Executive Officer & Director at Big Sky Petroleum Corp.
(2006-2008), CEO, Secretary & Non-Independent Director at Buffalo Capital, Inc., Chairman at Kane Biotech, Inc. (2001-2011), Director at DiaMedica Therapeutics, Inc. (2007-2008), Director at MEDA Investments, Inc. (2000-2012), Director at Waverley Pharma, Inc., and Member-Industrial Advisory Committee at Biotechnology Research Corp.Dr. Friesen obtained a doctorate degree from the University of Manitoba.
Dr. Friesen is also the founder of Winnipeg RH Institute Foundation, Inc., ABI Biotechnology, Inc., Genesys Pharma, Inc., KAM Scientific, Inc., Industrial Biotechnology Association of Canada.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
11/01/2024 2 602 955 ( 24,94% ) 2 M $ 31/03/2024
08/05/2023 40 292 000 ( 74,61% ) 967 008 $ 31/03/2024

Postes actifs de Albert Friesen

SociétésPosteDébut
MEDICURE INC. Chief Executive Officer 15/09/1997
WAVERLEY PHARMA INC. Chairman 14/12/2016
Chief Executive Officer 01/01/2006
Director/Board Member -
Chief Executive Officer -
Manitoba Innovation Council Chairman 20/05/2011
Canada Foundation For Innovation Director/Board Member 16/02/2010
Director/Board Member 25/11/2009
Founder 01/01/1997
░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Tous les postes actifs de Albert Friesen

Anciens postes connus de Albert Friesen

SociétésPosteFin
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Albert Friesen

Formation de Albert Friesen

University of Manitoba Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Albert Friesen

Relations

100 +

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées4
MEDICURE INC.

Health Technology

KANE BIOTECH INC.

Commercial Services

DIAMEDICA THERAPEUTICS INC.

Health Technology

WAVERLEY PHARMA INC.

Health Technology

Entreprise privées20

Health Technology

Commercial Services

Health Technology

Finance

Finance

Commercial Services

Industrial Biotechnology Association of Canada

Finance

Canada Foundation For Innovation

Miscellaneous

Winnipeg RH Institute Foundation, Inc.

ABI Biotechnology, Inc.

Genesys Pharma, Inc.

Process Industries

Finance

Electronic Technology

Manitoba Innovation Council

Energy Minerals

Finance

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Albert Friesen